Roundtable Discussion; The Future of Mineral Sands. Watch the video here.
All that stock piling of tests GDR been stored whilst awaiting confirmed orders was a clever move from the BOD's. Now watch all this stock get transported to India for short term support followed by tens Millions of tests to follow. Excellent revenue to be announced. M/C should be multiples of the current value with so much more to be announced
Shorter's panicking !!! spouting placing, got to laugh at times thou.
All in black and white GDR can continue without any revenue for at least 10 months.
The chances of some revenue from any of its four products within this time frame is almost certain.
Just more scare tactics from the shorter's.. ignore , sit back and let GDR profit in the coming weeks, months.
So much positive upside ahead against shorter's FOMO.
No need to check your screens daily here just hold and let GDR do it thing. Obviously shorter's are watching like a hawk hence why they should be worried.
#GDR.. Other products ready to be launch summer 2021 worth £35M-£50M for UK and US is the proven tested Hearing Loss tests for Babies. GDR have a very simple swap test identifying 1in500 Babies with defected hearing.
In addition awaiting an official order to land any time for its ' BIO PLEX ' for Military use via Mountain Horse solutions. This will bring in long awaited revenues.
So GDR have many other tests available and ready for immediate use as well as the SARS CoV 96 tests.
There is plenty in the pipeline, Any news of any of these products will rerate the sp well over the current M/C and probably with revenue figure see over 200p plus.
400K cash burn per month plus over £4M cash in the bank GDR can continue to manufacture and stock pile all of its products ready for delivery. No placing nor funds required as any of these products will bring huge revenues. News can land any day so FOMO for those sitting on the sidelines.
With cash in the bank and burn rate till end of the year, GDR are ready to GO. DB mention they have been stock piling supplies whilst waiting for the confirmed contracts by BC. Remember we also have 2 others test products due for release, one for the Military worth £10M-£15M ready for export to the US in Q2 and Test for Babies Hearing worth Globally @£50M. These two alone will push the sp back pass £1.50p easily followed by SARs CoV2 test supplies that will be worth multiple £10's M contracts all the way to 2023. Huge revenues about to hit GDR for 2021. Expect fireworks first sign of FDA approval.
Just topped up again thank you sellers, 156p a few days ago and bought more at 135.5p
When News land with sales orders we will see goodbye to £2 before moving further north. I still see an eventual buyout as these tests will be here for many years, Its wether GDR have the capacity to keep up with the sales demand especially from the US. I think not hence a buy out of the product and enjoy the royalties from every test. £300M purchase is nothing compared the the huge orders that can be achieved here, possibly many hundred of millions in the first year alone.
The facts are all here if you do your research. GDR are set up Globally and geared to Go.
producing and increasing their stock ready for dispatch.
Once figures for demand get released, GDR would have accumulated a huge stock. This won't be enough to support the 100'sM
of tests kits required but will certainly catapult their revenue instantly and a possible JV to help with the production demands.
Post 641 .... I did say, hope most of you had a little top up at that obvious shake yesterday.
MM's will still try and shake if they can but the news today only confirms GDR are heading north big time
Markets getting ready for the imminent news which will push the sp north to the next resistance pass £2 then £3.
The current MC does not reflect the true value of GDR. Expecting all time highs on news as we are still only £74M MC.
Treeshakes forcing sellers out but alway difficult to buy back.
If GDR are expected to produce millions of tests in a very short period then don't rule out a JV with a major.
So much positive news to land at any time
David Budd, CEO of genedrive plc said: "We have carried out detailed in silico analysis of 155,276 sequences on the GISAID database. The results show that the test is able to detect all published COVID-19 strains with the same high level of accuracy and demonstrates 100% homology."
A1 agree with your comments, This sort of agreements are the norm in other countries and most contracts are completed with some shenanigans behind the scenes. I expect a few sour competitors that lost out of the deal had not offered a big enough bribe. Either way a modest fine and thats about it.
taken from another bb post....
The drop was driven by the allegations of a former employer which will have no effect on the company. We have seen the sp from 180p to 102p... huge drop totally unjustified other than shorts being applied.
The last update confirms huge revenue for 2021 and quote as follows
" Looking ahead, the Group currently has US$3.0 billion of secured revenue for
2021, comprising US$2.2 billion in E&C and US$0.8 billion in EPS. In addition,
the Group has a pipeline of around US$42 billion of bids scheduled for award
by the end of 2021, comprising around US$31 billion of E&C opportunities and
around US$11 billion of EPS opportunities. Approximately 11% of the Group's
bidding pipeline consists of new energies opportunities."
I expect we will be at least 150-160 p rather sooner than later. The fall to this level is overdone.
Directors buy at 144.5p shows great confidence and may have inside knowledge of news to come. The drop in the sp was well overdone by the investigating allegations which the outcome will have little impact on PFC.
The bottom was reached today hence a rerate back to 160p plus